Alessandra Tessitore
Overview
Explore the profile of Alessandra Tessitore including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
1338
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Colaianni F, Zelli V, Compagnoni C, Miscione M, Rossi M, Vecchiotti D, et al.
Genes (Basel)
. 2024 Oct;
15(10).
PMID: 39457437
miR-122 is the most abundant microRNA (miRNA) in the liver; it regulates several genes mainly involved in cell metabolism and inflammation. Host factors, diet, metabolic disorders and viral infection promote...
2.
Rossetti A, Chonco L, Alegria N, Zelli V, Garcia A, Ramirez-Castillejo C, et al.
Pharmaceutics
. 2024 May;
16(5).
PMID: 38794272
Deer antlers are the fastest growing tissue. Because they are based on proto-oncogenes, to avoid the risk of cancer, antlers evolved strong anticancer mechanisms, and thus their extract (DVA) is...
3.
Ornello R, Zelli V, Compagnoni C, Caponnetto V, De Matteis E, Tiseo C, et al.
J Headache Pain
. 2024 May;
25(1):80.
PMID: 38755568
Background: Migraine lacks biomarkers that can trace the biological pathways of the disease and predict the effectiveness of treatments. Monoclonal antibodies targeting calcitonin gene-related peptide pathway - including erenumab -...
4.
Irelli A, Patruno L, Chiatamone Ranieri S, Di Giacomo D, Malatesta S, Alesse E, et al.
Biomedicines
. 2024 Apr;
12(4).
PMID: 38672070
Hereditary breast and ovarian cancer (HBOC) syndrome is responsible for approximately 10% of breast cancers (BCs). The HBOC gene panel includes both high-risk genes, i.e., a four times higher risk...
5.
Bianchi A, Zelli V, DAngelo A, Di Matteo A, Scoccia G, Cannita K, et al.
NAR Genom Bioinform
. 2024 Apr;
6(2):lqae033.
PMID: 38633426
In the rapidly evolving field of genomics, understanding the genetic basis of complex diseases like breast cancer, particularly its familial/hereditary forms, is crucial. Current methods often examine genomic variants-such as...
6.
Irelli A, Ceriello L, Patruno L, Tessitore A, Alesse E, Cannita K, et al.
Biomedicines
. 2024 Jan;
12(1).
PMID: 38255284
Pertuzumab and trastuzumab have been shown to improve the outcomes of patients with metastatic breast cancer, with a rate of left ventricular dysfunction of approximately 6%. We report the case...
7.
Zelli V, Manno A, Compagnoni C, Ibraheem R, Zazzeroni F, Alesse E, et al.
J Transl Med
. 2023 Nov;
21(1):836.
PMID: 37990214
Background: Machine learning (ML) represents a powerful tool to capture relationships between molecular alterations and cancer types and to extract biological information. Here, we developed a plain ML model aimed...
8.
Compagnoni C, Capelli R, Zelli V, Corrente A, Vecchiotti D, Flati I, et al.
Int J Mol Sci
. 2023 Jun;
24(11).
PMID: 37298191
Non-alcoholic fatty liver disease (NAFLD) is considered a relevant liver chronic disease. Variable percentages of NAFLD cases progress from steatosis to steatohepatitis (NASH), cirrhosis and, eventually, hepatocellular carcinoma (HCC). In...
9.
Clementi L, Sabetta S, Zelli V, Compagnoni C, Tessitore A, Mattei V, et al.
J Cancer Res Clin Oncol
. 2023 Mar;
149(10):7689-7701.
PMID: 37000265
Purpose: Tau/MAPT (microtubule associated protein tau) protein is actively studied for the pathologic consequences of its aberrant proteostasis in central nervous system leading to neurodegenerative diseases. Besides its ability to...
10.
Irelli A, Chiatamone Ranieri S, Di Giacomo D, Malatesta S, Patruno L, Tessitore A, et al.
Cancers (Basel)
. 2023 Mar;
15(6).
PMID: 36980613
Molecular tumor boards (MTBs) are multidisciplinary groups that combine molecular and clinical data from cancer patients in order to formulate treatment recommendations for precision medicine. To date, there is insufficient...